Targeted therapy is?a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report contains market size and forecasts of Cancer Targeted Small Molecule Therapy in Global, including the following market information:
Global Cancer Targeted Small Molecule Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Targeted Small Molecule Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Sorafenib Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cancer Targeted Small Molecule Therapy include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Targeted Small Molecule Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Targeted Small Molecule Therapy Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Cancer Targeted Small Molecule Therapy Market Segment Percentages, by Type, 2022 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Cancer Targeted Small Molecule Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Cancer Targeted Small Molecule Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Cancer Targeted Small Molecule Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Cancer Targeted Small Molecule Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Targeted Small Molecule Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Targeted Small Molecule Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Targeted Small Molecule Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Targeted Small Molecule Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Targeted Small Molecule Therapy Overall Market Size
2.1 Global Cancer Targeted Small Molecule Therapy Market Size: 2022 VS 2030
2.2 Global Cancer Targeted Small Molecule Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Targeted Small Molecule Therapy Players in Global Market
3.2 Top Global Cancer Targeted Small Molecule Therapy Companies Ranked by Revenue
3.3 Global Cancer Targeted Small Molecule Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Targeted Small Molecule Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Targeted Small Molecule Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Targeted Small Molecule Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Targeted Small Molecule Therapy Market Size Markets, 2022 & 2030
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Targeted Small Molecule Therapy Revenue, 2023-2030
4.2.3 By Type - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Targeted Small Molecule Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Targeted Small Molecule Therapy Revenue, 2023-2030
5.2.3 By Application - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Targeted Small Molecule Therapy Market Size, 2022 & 2030
6.2 By Region - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Targeted Small Molecule Therapy Revenue, 2023-2030
6.2.3 By Region - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Targeted Small Molecule Therapy Revenue, 2018-2030
6.3.2 US Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.3.3 Canada Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.3.4 Mexico Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, 2018-2030
6.4.2 Germany Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4.3 France Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4.4 U.K. Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4.5 Italy Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4.6 Russia Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.4.8 Benelux Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, 2018-2030
6.5.2 China Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.5.3 Japan Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.5.4 South Korea Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.5.6 India Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Targeted Small Molecule Therapy Revenue, 2018-2030
6.6.2 Brazil Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.6.3 Argentina Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, 2018-2030
6.7.2 Turkey Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.7.3 Israel Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
6.7.5 UAE Cancer Targeted Small Molecule Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Cancer Targeted Small Molecule Therapy Major Product Offerings
7.1.4 Bayer Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Cancer Targeted Small Molecule Therapy Major Product Offerings
7.2.4 Eisai Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News
7.3 Zelgen
7.3.1 Zelgen Corporate Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Cancer Targeted Small Molecule Therapy Major Product Offerings
7.3.4 Zelgen Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Cancer Targeted Small Molecule Therapy Major Product Offerings
7.4.4 Cipla Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News
7.5 Natco Pharma
7.5.1 Natco Pharma Corporate Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.5.4 Natco Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cancer Targeted Small Molecule Therapy Major Product Offerings
7.6.4 AstraZeneca Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Cancer Targeted Small Molecule Therapy Major Product Offerings
7.7.4 Novartis Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Cancer Targeted Small Molecule Therapy Major Product Offerings
7.8.4 Roche Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Cancer Targeted Small Molecule Therapy Major Product Offerings
7.10.4 Pfizer Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News
7.11 BEACON Pharma
7.11.1 BEACON Pharma Corporate Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.11.4 BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Corporate Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News
7.13 Yao Pharma
7.13.1 Yao Pharma Corporate Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.13.4 Yao Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News
7.14 CSPC
7.14.1 CSPC Corporate Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Cancer Targeted Small Molecule Therapy Major Product Offerings
7.14.4 CSPC Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Corporate Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News
7.16 Simcere
7.16.1 Simcere Corporate Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Cancer Targeted Small Molecule Therapy Major Product Offerings
7.16.4 Simcere Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Targeted Small Molecule Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Targeted Small Molecule Therapy Market Drivers in Global Market
Table 3. Cancer Targeted Small Molecule Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Targeted Small Molecule Therapy in Global Market
Table 5. Top Cancer Targeted Small Molecule Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Targeted Small Molecule Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Targeted Small Molecule Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Targeted Small Molecule Therapy Product Type
Table 9. List of Global Tier 1 Cancer Targeted Small Molecule Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2023-2030
Table 30. Bayer Corporate Summary
Table 31. Bayer Cancer Targeted Small Molecule Therapy Product Offerings
Table 32. Bayer Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Eisai Corporate Summary
Table 34. Eisai Cancer Targeted Small Molecule Therapy Product Offerings
Table 35. Eisai Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Zelgen Corporate Summary
Table 37. Zelgen Cancer Targeted Small Molecule Therapy Product Offerings
Table 38. Zelgen Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 39. Cipla Corporate Summary
Table 40. Cipla Cancer Targeted Small Molecule Therapy Product Offerings
Table 41. Cipla Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 42. Natco Pharma Corporate Summary
Table 43. Natco Pharma Cancer Targeted Small Molecule Therapy Product Offerings
Table 44. Natco Pharma Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Cancer Targeted Small Molecule Therapy Product Offerings
Table 47. AstraZeneca Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 48. Novartis Corporate Summary
Table 49. Novartis Cancer Targeted Small Molecule Therapy Product Offerings
Table 50. Novartis Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Roche Corporate Summary
Table 52. Roche Cancer Targeted Small Molecule Therapy Product Offerings
Table 53. Roche Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Product Offerings
Table 56. Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Cancer Targeted Small Molecule Therapy Product Offerings
Table 59. Pfizer Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 60. BEACON Pharma Corporate Summary
Table 61. BEACON Pharma Cancer Targeted Small Molecule Therapy Product Offerings
Table 62. BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Jiangxi Shanxiang Corporate Summary
Table 64. Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Product Offerings
Table 65. Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Yao Pharma Corporate Summary
Table 67. Yao Pharma Cancer Targeted Small Molecule Therapy Product Offerings
Table 68. Yao Pharma Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 69. CSPC Corporate Summary
Table 70. CSPC Cancer Targeted Small Molecule Therapy Product Offerings
Table 71. CSPC Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 72. CHIATAI Tianqing Corporate Summary
Table 73. CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Product Offerings
Table 74. CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
Table 75. Simcere Corporate Summary
Table 76. Simcere Cancer Targeted Small Molecule Therapy Product Offerings
Table 77. Simcere Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Cancer Targeted Small Molecule Therapy Segment by Type in 2022
Figure 2. Cancer Targeted Small Molecule Therapy Segment by Application in 2022
Figure 3. Global Cancer Targeted Small Molecule Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Targeted Small Molecule Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Targeted Small Molecule Therapy Revenue in 2022
Figure 8. By Type - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 12. US Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 16. Germany Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 24. China Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. Bayer Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Eisai Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Zelgen Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Cipla Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Natco Pharma Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Yao Pharma Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CSPC Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Simcere Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
